Antimicrobial resistance (AMR) is a fancy problem of world concern with doubtlessly dramatic well being and financial penalties.
The OECD gives international locations with the proof to implement efficient and cost-effective One Well being insurance policies to deal with AMR, promote efficient use of antimicrobials in human and animal well being, strengthen an infection prevention and management measures, and incentivise analysis and growth within the antibiotic sector.
LATEST EVENT – HIGH-LEVEL ONE HEALTH MINISTERIAL CONFERENCE ON ANTIMICROBIAL RESISTANCE
Excessive-Stage One Well being Ministerial Assembly On Antimicrobial Resistance, French Presidency of the EU Council
The OECD, in collaboration with the European Centre for Illness Prevention and Management, the European Meals Security Authority and the European Medicines Company, has produced a briefing notice on antimicrobial resistance (AMR) within the European Union and European Financial Space. It presents tendencies in antibiotic consumption and AMR from a One Well being perspective, and units out coverage choices for nationwide governments and the European Union.
Key paperwork on antimicrobial resistance
G7 WORK ON AMR
The G7 has constantly dedicated to tackling world well being challenges, together with the battle towards infectious ailments, and positioned itself as a number one companion in reaching health-related Millennium Improvement Objectives, by initiating and supporting many world devices of response to threats posed by infectious ailments. The findings introduced on this report present that there’s a sturdy case for G7 motion within the space of AMR.
G20 WORK ON AMR
Learn the note prepared for the G20 by OECD together with WHO, FAO and OIE, on potential methods to deal with antimicrobial resistance (AMR) and guarantee sustainable analysis and growth (R&D) for brand new antibiotics. The notice requires motion based mostly on a coordinated and cross-sectoral strategy below the ‘One Well being’ framework, highlights the pressing want to deal with limitations to innovation and suggests coverage and governance mechanisms to reactivate the antibiotic R&D pipeline.
Within the Hamburg G20 declaration, leaders known as for a brand new R&D Collaboration Hub and dedicated to additional study sensible market incentive choices, in collaboration with related specialists together with from the OECD and the WHO.
For extra info, please contact email@example.com